Dimethylformamide → (2-(Pyrid-4-yl)-1H-benzimidazole-4-carbonyl)-(L)-valinamide

HRID 278032

Reaktionsgleichung

Reaktionsgleichung von HRID 278032
[N:1]1[CH:6]=[CH:5][C:4]([C:7]2[NH:11][C:10]3[CH:12]=[CH:13][CH:14]=[C:15]([C:16]([OH:18])=O)[C:9]=3[N:8]=2)=[CH:3][CH:2]=1.[B-](F)(F)(F)F.CCO[C:27]([C:29]([C:39]#[N:40])=NOC(N(C)C)=[N+](C)C)=O.[CH:41](N(C(C)C)CC)(C)C.C[N:51]([CH:53]=[O:54])C>>[N:1]1[CH:2]=[CH:3][C:4]([C:7]2[NH:11][C:10]3[CH:12]=[CH:13][CH:14]=[C:15]([C:16]([NH:40][C@H:39]([C:53]([NH2:51])=[O:54])[CH:29]([CH3:41])[CH3:27])=[O:18])[C:9]=3[N:8]=2)=[CH:5][CH:6]=1

Komponenten

5

Versuchsvorschrift

120 mg (0.5 mmol) of 2-(pyrid-4-yl)-1H-benzimidazole-4-carboxylic acid (1d) and 76.4 mg (0.5 mmol) of H-(L)-valinamide were dissolved in 5 ml of DMF. 164 mg (0.5 mmol) of TOTU and 0.086 ml of diisopropylethylamine were added and the mixture was stirred at RT for 3 h. The precipitate was filtered off and the filtrate was concentrated. The residue was dissolved in ethyl acetate, the solution was washed with saturated sodium chloride solution, and the organic phase was dried using anhydride sodium sulfate and concentrated. Yield: 168 mg (99%). (M+H)+=338.2 (Cl+).

Aufarbeitung

  1. filtrationThe precipitate was filtered off
  2. concentrationthe filtrate was concentrated
  3. dissolutionThe residue was dissolved in ethyl acetate
  4. washthe solution was washed with saturated sodium chloride solution
  5. customthe organic phase was dried
  6. concentrationconcentrated

Quellen und Nachweise

ORD-Eintrag
ord-cc209c226de84ecb942c3b52c5f48169
Quelldatensatz
uspto-grants-2002_03
Patentnummer
US06358978B1

Verknüpfte Notizen

Wird geladen…